Wang, Yi http://orcid.org/0000-0001-8601-8487
Yu, Ming
Yan, Brian
Martin, Patrick
Robertson, Brigitte
Funding for this research was provided by:
Shire Development LLC, Lexington, MA, USA, a member of the Takeda group of companies
Article History
First Online: 26 March 2019
Compliance with Ethical Standards
:
: This clinical research was funded by the sponsor, Shire Development LLC, Lexington, MA, USA, a member of the Takeda group of companies. Shire Development LLC, Lexington, MA, USA, a member of the Takeda group of companies, provided funding to CHC for support in writing and editing this article.
: Yi Wang, Ming Yu, Brian Yan, Patrick Martin, and Brigitte Robertson are employees of Shire, a member of the Takeda group of companies, and hold Takeda stock and/or stock options.
: The study protocol and informed consent form were approved by the Covance Clinical Research Unit Institutional Review Board (Madison, WI, USA). The study protocol was conducted in accordance with the principles of the 18th World Medical Assembly and amendments of the 29th, 35th, 41st, and 48th World Medical Assemblies.
: All participants were required to give informed consent after having received written information and an explanation of the study; no study procedures were conducted before consent was provided.
: The datasets generated during and/or analyzed during the current study are not publicly available.